Prio Wealth Limited Partnership bought a new position in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 28,800 shares of the biotechnology company’s stock, valued at approximately $852,000. Prio Wealth […]
Portolan Capital Management LLC reduced its position in Anika Therapeutics, Inc. (NASDAQ:ANIK – Get Rating) by 11.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 207,900 shares of the biotechnology company’s stock after selling 26,703 shares during the period. Portolan Capital […]
StockNews.com initiated coverage on shares of Anika Therapeutics (NASDAQ:ANIK – Get Rating) in a report issued on Thursday. The firm issued a hold rating on the biotechnology company’s stock. Several other brokerages have also issued reports on ANIK. Barrington Research lowered Anika Therapeutics from an outperform rating to a market perform rating in a research […]
StockNews.com started coverage on shares of Anika Therapeutics (NASDAQ:ANIK – Get Rating) in a report released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. ANIK has been the subject of several other research reports. Stephens reaffirmed an equal weight rating and set a $28.00 price objective on shares of Anika […]
Anika Therapeutics, Inc. (NASDAQ:ANIK – Get Rating) – Investment analysts at Barrington Research dropped their Q2 2023 earnings per share estimates for Anika Therapeutics in a report released on Wednesday, May 10th. Barrington Research analyst M. Petusky now expects that the biotechnology company will post earnings of ($0.27) per share for the quarter, down from […]